Nonpharmacological modulation of dynamic hyperinflation

European Respiratory Review

Volumn 15, Issue 100, 2006, Pages 90-95

  Wouters, E F M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chronic obstructive pulmonary disease; Heliox breathing; Hyperinflation; Hyperoxia; Noninvasive ventilation; Pulmonary rehabilitation

Indexed keywords

BRONCHODILATING AGENT; HELIUM; OXYGEN;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; DISEASE COURSE; EXPIRATORY FLOW; HUMAN; HYPERINFLATION; HYPEROXIA; LUNG COLLAPSE; LUNG FUNCTION; LUNG VENTILATION; LUNG VOLUME; OXYGEN BREATHING; OXYGEN CONSUMPTION; POSITIVE END EXPIRATORY PRESSURE; PULMONARY REHABILITATION;

EID: 34447133522     PISSN: 09059180     EISSN: None     Source Type: Journal    
DOI: 10.1183/09059180.00010007     Document Type: Conference Paper

References (61)

1. Calverley PM, Koulouris NG. Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology. Eur Respir J 2005; 25: 186-199.
2. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968; 278: 1355-1360.
3. Yanai M, Sekizawa K, Ohrui T, et al. Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J Appl Physiol 1992; 72: 1016-1023.
4. O'Donnell DE, Bertley JC, Chau LK, et al. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 1997; 155: 109-115.
5. O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 770-777.
6. Stubbing DG, Pengelly LD, Morse JL, et al. Pulmonary mechanics during exercise in subjects with chronic airflow obstruction. J Appl Physiol 1980; 49: 511-515.
7. Aliverti A, Stevenson N, Dellaca RL, et al. Regional chest wall volumes during exercise in chronic obstructive pulmonary disease. Thorax 2004; 59: 210-216.
8. Tantucci C, Duguet A, Similowski T, et al. Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients. Eur Respir J 1998; 12: 799-804.
9. Boni E, Corda L, Franchini D, et al. Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest. Thorax 2002; 57: 528-532.
10. Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 967-975.
11. O'Donnell DE, Voduc N, Fitzpatrick M, et al. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 2004; 24: 86-94.
12. O'Donnell DE, Fluge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004; 23: 832-840.
13. Stein DA, Bradley BL, Miller WC. Mechanisms of oxygen effects on exercise in patients with chronic obstructive pulmonary disease. Chest 1982; 81: 6-10.
14. Bradley BL, Garner AE, Billiu D, et al. Oxygen-assisted exercise in chronic obstructive lung disease. The effect on exercise capacity and arterial blood gas tensions. Am Rev Respir Dis 1978; 118: 239-243.
15. Bye PT, Esau SA, Levy RD, et al. Ventilatory muscle function during exercise in air and oxygen in patients with chronic airflow limitation. Am Rev Respir Dis 1985; 132: 236-240.
16. Dean NC, Brown JK, Himelman RB, et al. Oxygen may improve dyspnea and endurance in patients with chronic obstructive pulmonary disease and only mild hypoxemia. Am Rev Respir Dis 1992; 146: 941-945.
17. Swinburn CR, Wakefield JM, Jones PW. Relationship between ventilation and breathlessness during exercise in chronic obstructive airways disease is not altered by prevention of hypoxaemia. Clin Sci (Lond) 1984; 67: 515-519.
18. Lane R, Cockcroft A, Adams L, et al. Arterial oxygen saturation and breathlessness in patients with chronic obstructive airways disease. Clin Sci (Lond) 1987; 72: 693-698.
19. Woodcock AA, Gross ER, Geddes DM. Oxygen relieves breathlessness in "pink puffers". Lancet 1981; 1: 907-909.
20. Light RW, Mahutte CK, Stansbury DW, et al. Relationship between improvement in exercise performance with supplemental oxygen and hypoxic ventilatory drive in patients with chronic airflow obstruction. Chest 1989; 95: 751-756.
21. Swinburn CR, Mould H, Stone TN, et al. Symptomatic benefit of supplemental oxygen in hypoxaemic patients with chronic lung disease. Am Rev Respir Dis 1991; 143: 913-915.
22. O'Donnell DE, Bain DJ, Webb KA. Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. Am J Respir Crit Care Med 1997; 155: 530-535.
23. O'Donnell DE, D'Arsigny C, Webb KA. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 892-898.
24. Alvisi V, Mirkovic T, Nesme P, et al. Acute effects of hyperoxia on dyspnea in hypoxemia patients with chronic airway obstruction at rest. Chest 2003; 123: 1038-1046.
25. Sorli J, Grassino A, Lorange G, et al. Control of breathing in patients with chronic obstructive lung disease. Clin Sci Mol Med 1978; 54: 295-304.
26. Peters MM, Webb KA, O'Donnell DE. Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD. Thorax 2006; 61: 559-567.
27. Somfay A, Porszasz J, Lee SM, et al. Dose-response effect of oxygen on hyperinflation and exercise endurance in non-hypoxaemic COPD patients. Eur Respir J 2001; 18: 77-84.
28. Nandi K, Smith AA, Crawford A, et al. Oxygen supplementation before or after submaximal exercise in patients with chronic obstructive pulmonary disease. Thorax 2003; 58: 670-673.
29. Lewis CA, Eaton TE, Young P, et al. Short-burst oxygen immediately before and after exercise is ineffective in nonhypoxic COPD patients. Eur Respir J 2003; 22: 584-588.
30. Stevenson NJ, Calverley PM. Effect of oxygen on recovery from maximal exercise in patients with chronic obstructive pulmonary disease. Thorax 2004; 59: 668-672.
31. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173: 1390-1413.
32. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines. ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel. American College of Chest Physicians. American Association of Cardiovascular and Pulmonary Rehabilitation. Chest 1997; 112: 1363-1396.
33. Lacasse Y, Brosseau L, Milne S, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 2002: CD003793.
34. O'Donnell DE, McGuire M, Samis L, et al. The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation. Am J Respir Crit Care Med 1995; 152: 2005-2013.
35. Reardon J, Awad E, Normandin E, et al. The effect of comprehensive outpatient pulmonary rehabilitation on dyspnea. Chest 1994; 105: 1046-1052.
36. Ries AL, Kaplan RM, Limberg TM, et al. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995; 122: 823-832.
37. Weiner P, Azgad Y, Ganam R. Inspiratory muscle training combined with general exercise reconditioning in patients with COPD. Chest 1992; 102: 1351-1356.
38. Simpson K, Killian K, McCartney N, et al. Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation. Thorax 1992; 47: 70-75.
39. Hernandez MT, Rubio TM, Ruiz FO, et al. Results of a home-based training program for patients with COPD. Chest 2000; 118: 106-114.
40. Cambach W, Chadwick-Straver RV, Wagenaar RC, et al. The effects of a community-based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial. Eur Respir J 1997; 10: 104-113.
41. Porszasz J, Emtner M, Goto S, et al. Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest 2005; 128: 2025-2034.
42. Sturdy G, Hillman D, Green D, et al. Feasibility of high-intensity, interval-based respiratory muscle training in COPD. Chest 2003; 123: 142-150.
43. Barach AL. The use of helium in the treatment of asthma and obstructive lesions in the larynx and trachea. Ann Intern Med 1935; 9: 739-765.
44. Dawson SV, Elliott EA. Wave-speed limitation on expiratory flow - a unifying concept. J Appl Physiol 1977; 43: 498-515.
45. Mc IM, Mead J, Selverstone NJ, et al. Measurement of lung tissue viscous resistance using gases of equal kinematic viscosity. J Appl Physiol 1955; 7: 485-490.
46. Wouters EF, Landser FJ, Polko AH, et al. Impedance measurement during air and helium-oxygen breathing before and after salbutamol in COPD patients. Clin Exp Pharmacol Physiol 1992; 19: 95-101.
47. Wilson T, Rodarte J, Butler JP. Wave-speed and viscous flow limitation. Macklem PT, Mead J, eds. Handbook of Physiology: the Respiratory System, vol. III. Baltimore, American Physiological Society, 1986; pp. 55-61.
48. Dosman J, Bode F, Urbanetti J, et al. The use of a helium-oxygen mixture during maximum expiratory flow to demonstrate obstruction in small airways in smokers. J Clin Invest 1975; 55: 1090-1099.
49. Grape B, Channin E, Tyler JM. The effect of helium and oxygen mixtures on pulmonary resistances in emphysema. Am Rev Respir Dis 1960; 81: 823-829.
50. Swidwa DM, Montenegro HD, Goldman MD, et al. Helium-oxygen breathing in severe chronic obstructive pulmonary disease. Chest 1985; 87: 790-795.
51. 2. J Appl Physiol 1997; 82: 746-754.
52. Pecchiari M, Pelucchi A, D'Angelo E, et al. Effect of heliox breathing on dynamic hyperinflation in COPD patients. Chest 2004; 125: 2075-2082.
53. Palange P, Valli G, Onorati P, et al. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. J Appl Physiol 2004; 97: 1637-1642.
54. Brochard L, Mancebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995; 333: 817-822.
55. Plant PK, Owen JL, Elliott MW. Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet 2000; 355: 1931-1935.
56. Peter JV, Moran JL, Phillips-Hughes J, et al. Noninvasive ventilation in acute respiratory failure - a meta-analysis update. Crit Care Med 2002; 30: 555-562.
57. Liesching T, Kwok H, Hill NS. Acute applications of noninvasive positive pressure ventilation. Chest 2003; 124: 699-713.
58. Rossi A. Noninvasive ventilation has not been shown to be ineffective in stable COPD. Am J Respir Crit Care Med 2000; 161: 688-689.
59. Elliott MW, Mulvey DA, Moxham J, et al. Domiciliary nocturnal nasal intermittent positive pressure ventilation in COPD: mechanisms underlying changes in arterial blood gas tensions. Eur Respir J 1991; 4: 1044-1052.
60. Diaz O, Begin P, Torrealba B, et al. Effects of noninvasive ventilation on lung hyperinflation in stable hypercapnic COPD. Eur Respir J 2002; 20: 1490-1498.
61. Budweiser S, Heinemann F, Fischer W, et al. Long-term reduction of hyperinflation in stable COPD by non-invasive nocturnal home ventilation. Respir Med 2005; 99: 976-984.